PATENT CLAIM ANALYSIS

Application Number: 15959318
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "234200"]

Abstract:
The present invention is related to pyrazolo pyridine derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).

Claim (Index 4):
The method according to  claim 1 , wherein said cardiovascular disorders, respiratory disorders, metabolism disorders, skin disorders, bone disorders, neuroinflammatory and/or neurodegenerative disorders, kidney diseases, reproduction disorders, diseases affecting the eye and/or the lens and/or conditions affecting the inner ear, inflammatory disorders, pain, cancers, allergic disorders, traumatisms, septic, hemorrhagic and anaphylactic shock, disorders of the gastrointestinal system, angiogenesis, angiogenesis-dependent conditions and other diseases and disorders associated with Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase) are selected from the group consisting of pulmonary hypertension, COPD, a cancer selected from acute myeloid leukemia, skin cancer, colon cancer, prostate cancer, breast cancer, pancreatic cancer, renal cancer, laryngeal cancer, ovarian cancer, colorectal cancer, head and neck cancer, testicular cancer, lymphoid cancer, marrow cancer, bone cancer, sarcoma, renal cancer, sweat gland cancer, lung cancer, lung carcinoma hepatocellular carcinoma and prostatic carcinoma, hypertension, atherosclerosis, pulmonary fibrosis, pulmonary hypertension, Alzheimer's disease, diabetes, asthma, hearing loss and balance problems in response to ototoxic drugs, vascular injuries after balloon surgery, inflammation, cardiovascular complications of type I or type II diabetes, intimal hyperplasia, coronary heart disease, cerebral, coronary or arterial vasospasm, endothelial dysfunction, inflammatory bowel disease, Crohn's disease, multiple sclerosis and pain.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 91.0
- Lexical Diversity: 1.16216
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13755617', '13120438', '14750019', '13120440', '13734205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8583165134040086
- 35 USC 102 Novelty (BERT): 0.6139364617554615
- Combined Prediction Score: 0.8338785082391539
- Mean Citation Score: 637.4256419999998
- Max Citation Score: 646.59875
- Similarity Product: 468.37523524217306

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test